Novo Nordisk is acquiring three manufacturing sites from Catalent as it seeks to keep up with patient demand for weight-loss drug Wegovy.
Source link : https://www.washingtonpost.com/business/2024/02/05/novo-nordisk-catalent-wegovy-ozempic/
Author : Daniel Gilbert
Publish date : 2024-02-05 19:11:51
Copyright for syndicated content belongs to the linked Source.
Novo Nordisk buys manufacturing power as it seeks to ramp up Wegovy
